Good Health is Your Greatest Wealth……Virgil
The 1,708-patient trial to assess chelation therapy (TACT) was launched in 2002 under the auspices of the National Heart Lung and Blood Institute and the National Center for Complementary and Alternative Medicine. Patients in the study were treated …
See all stories on this topic »
TACT was funded by the NIH more than a decade ago as part of a much-publicized initiative to study the claims of alternative medicine. In 2008 enrollment in TACT was temporarily suspended in response to claims that the trial was unethical. The trial …
See all stories on this topic »
The $30 million TACT trial, sponsored by the National Center for Complementary and Alternative Medicine (NCCAM) and the National Institutes of Health, was stopped in 2008 while "allegations of impropriety" were investigated. These centered on concerns …
See all stories on this topic »